Skip to main content

David Murray, Ying Xu, Frank Guarnieri, James Bergey


David Murray has left his position as senior vice president of sales, marketing, and business development at Gene Logic to join Adjuvant, a Fairfax, Va.-based life sciences management consulting firm, as president.


The Knoxville News-Sentinel reported last week that Ying Xu, a group leader in the protein informatics group at Oak Ridge National Laboratory, has accepted an endowed position at the University of Georgia as the first bioinformatics scholar in the university’s Eminent Scholars program. Xu will leave ORNL in September, the paper reported, but “plans to return on a regular basis and work on developing new relationships between the University of Georgia and the national laboratory.”


Frank Guarnieri, formerly group head of biophysics and bioinformatics at Sarnoff Corporation, has joined Locus Pharmaceuticals as principal founding scientist. Guarnieri invented the computational technology that Locus licensed from Sarnoff Corporation to establish the company in 1999. The company also appointed James Bergey as VP of business development, a position he previously held at NeoPharm.


Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.